摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-C-(hydroxymethyl)-2,3:5,6-di-O-isopropylidene-α-D-mannofuranose | 91738-34-0

中文名称
——
中文别名
——
英文名称
2-C-(hydroxymethyl)-2,3:5,6-di-O-isopropylidene-α-D-mannofuranose
英文别名
(3aS,4S,6R,6aS)-6-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3a-(hydroxymethyl)-2,2-dimethyl-6,6a-dihydro-4H-furo[3,4-d][1,3]dioxol-4-ol
2-C-(hydroxymethyl)-2,3:5,6-di-O-isopropylidene-α-D-mannofuranose化学式
CAS
91738-34-0
化学式
C13H22O7
mdl
——
分子量
290.313
InChiKey
SGJOYWAHFNJARE-NKGMTQDZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    86.6
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of 3-C-(hydroxymethyl)erythritol and 3-C-methylerythritol
    作者:Zbigniew J. Witczak、Roy L. Whistler、James R. Daniel
    DOI:10.1016/0008-6215(84)85201-5
    日期:1984.10
    3-C-(Hydroxymethyl)erythritol was prepared from 3-C-(hydroxymethyl)-2,3-O-isopropylidene-D-erythro-tetrofuranose (4) by hydrolysis followed by reduction, or by reduction followed by hydrolysis. Monotosylation of 4, followed by reduction with lithium aluminum hydride and hydrolysis, afforded 3-C-methylerythritol.
    由3-C-(羟甲基)-2,3-O-异亚丙基-D-赤型-四呋喃糖(4)通过水解然后还原,或通过还原然后水解来制备3-C-(羟甲基)赤藓糖醇。4的单甲苯磺酰化,然后用氢化铝锂还原并水解,得到3-C-甲基赤藓糖醇。
  • Synthesis of differentially protected cyclopentitol: its application towards the stereoselective synthesis of 5-epi-calditol
    作者:C.V. Ramana、Bethi Sridhar Reddy、Mukund K. Gurjar
    DOI:10.1016/j.tetlet.2004.02.020
    日期:2004.3
    The synthesis of differentially protected cyclopentitol derivative 5 is described using ring-closing metathesis of a diene derived froni D-mannose. Subsequent chemical 11 modifications such as catalytic osmylation and chain extension using glycidyl triflate completed the synthesis of 5-epi-calditol. (C) 2004 Elsevier Ltd. All rights reserved.
  • Branched-chain alditols. A convenient synthesis of 6-deoxy-2-O-methyl-D-mannitol and 2-C-(hydroxymethyl)-D-mannitol
    作者:Zbigniew J. Witczak、Roy L. Whistler
    DOI:10.1016/0008-6215(87)80257-4
    日期:1987.11
  • Synthesis of 2-C-branched derivatives of d-mannose: 2-C-aminomethyl-d-mannose binds to the human C-type lectin DC-SIGN with affinity greater than an order of magnitude compared to that of d-mannose
    作者:Daniel A. Mitchell、Nigel A. Jones、Stuart J. Hunter、Joseph M.D. Cook、Sarah F. Jenkinson、Mark R. Wormald、Raymond A. Dwek、George W.J. Fleet
    DOI:10.1016/j.tetasy.2007.06.003
    日期:2007.7
    2-C-Substituted branched D-mannose analogues are novel monosaccharides, readily obtained from a Kiliani-acetonation sequence on D-fructose, followed by subsequent functional group manipulation. 2-C-Azidomethyl-D-mannose and 2-C-aminomethylD-marmose bind to the C-type lectin DC-SIGN (CD209) with significantly greater affinity than mannose. In particular, 2-C-aminomethyl-D-mannose exhibits a comparative 48-fold increase in binding as determined using a surface plasmon resonance-based competition assay. DC-SIGN is an important cell-surface type II transmembrane protein that interacts with blood group antigens, endogenous glycoproteins such as ICAM-3, and also deadly pathogens such as the human immunodeficiency and hepatitis C viruses. The effective use of small compounds to block target binding by mannose-selective C-type lectins at sub-millimolar concentrations has not been shown previously; thus, these data represent a very attractive thoroughfare to novel antiviral and immunomodulatory drug development. @ 2007 Elsevier Ltd. All rights reserved.
  • Synthesis of Ovalicin Starting from <scp>d</scp>-Mannose
    作者:Shunya Takahashi、Nobuyuki Hishinuma、Hiroyuki Koshino、Tadashi Nakata
    DOI:10.1021/jo051686m
    日期:2005.11.1
    A new synthesis of epoxyketone 22 is described that is a key intermediate in Barton's synthesis of ovalicin (2), a powerful anti-angiogenetic inhibitor. The key process for the construction of 22 was ring-closing metathesis of olefins 11 and 12 obtained from 2,3:5,6-di-O-isopropylidene-α-d-mannofuranose (4) and regioselective desilylation of tri-TES ether 19. Furthermore, an alternative stereoselective
    描述了环氧酮22的新合成方法,它是Barton合成卵磷脂(2)(一种强大的抗血管生成抑制剂)的关键中间体。构造22的关键过程是从2,3:5,6-二-O-异亚丙基-α - d-甘露呋喃糖(4)获得的烯烃11和12的闭环复分解和tri-TES醚的区域选择性脱甲硅烷基化19。此外,从一个替代立体选择性路线22到2也已开发,和的总产率2从4为10.0%。
查看更多